focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,773.00
Bid: 1,772.00
Ask: 1,773.00
Change: -10.50 (-0.59%)
Spread: 1.00 (0.056%)
Open: 1,773.50
High: 1,779.00
Low: 1,764.50
Prev. Close: 1,783.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS: SocGen Upgrades BT To Buy From Hold

Fri, 16th Jan 2015 09:36

LONDON (Alliance News) - The following UK shares received analyst recommendations Friday morning and Thursday afternoon:
----------
FTSE 100
----------
SOCGEN RAISES BT GROUP TO 'BUY' ('HOLD') - PRICE TARGET 480 (245) PENCE
----------
NUMIS CUTS RANDGOLD RESOURCES TO 'HOLD' ('BUY') - TARGET 5200 (4900) PENCE
----------
NUMIS CUTS ANTOFAGASTA TO 'REDUCE' ('HOLD') - TARGET 600 (700) PENCE
----------
S&P CAPITAL IQ RAISES ASSOCIATED BRITISH FOODS PRICE TARGET TO 2500 (2250) PENCE; LEAVES AT 'STRONG SELL'
----------
GOLDMAN CUTS BRITISH AMERICAN TOBACCO PRICE TARGET TO 3142 (3150) PENCE - 'SELL'
----------
GOLDMAN CUTS DIAGEO PRICE TARGET TO 1865 (1930) PENCE - 'NEUTRAL'
----------
CREDIT SUISSE RAISES INTERNATIONAL AIRLINES GROUP PRICE TARGET TO 678 (654) PENCE - 'OUTPERFORM'
----------
TRADERS: NOMURA CUTS PRICE TARGET BRITISH AMERICAN TOBACCO TO 2870 (4060) PENCE
----------
TRADERS: NOMURA RAISES IMPERIAL TOBACCO PRICE TARGET TO 2510 (2490) PENCE
----------
MORGAN STANLEY RAISES IMPERIAL TOBACCO PRICE TARGET TO 3250 (2680) PENCE - 'OVERWEIGHT'
----------
TRADERS: NOMURA RAISES EXPERIAN PRICE TARGET TO 1215 (1200) PENCE
----------
BARCLAYS CUTS SHIRE TO 'EQUAL WEIGHT' ('OVERWEIGHT') - TARGET 5000 (4535) PENCE
----------
BARCLAYS CUTS ASTRAZENECA TO 'UNDERWEIGHT' ('EQUAL WEIGHT')
----------
BARCLAYS CUTS ASTRAZENECA PRICE TARGET TO 4600 (4400) PENCE
----------
BARCLAYS RAISES GLAXOSMITHKLINE PRICE TARGET TO 1700 (1600) PENCE - 'OVERWEIGHT'
----------
BARCLAYS CUTS TULLOW OIL PRICE TARGET TO 550 (600) PENCE - 'OVERWEIGHT'
----------
TRADERS: INVESTEC RAISES RBS TO 'HOLD' ('SELL')
----------
BARCLAYS RAISES BARRATT DEVELOPMENTS TARGET TO 507.3 (501.2) P - 'OVERWEIGHT'
----------
GOLDMAN RAISES BARRATT DEVELOPMENTS PRICE TARGET TO 502 (500) PENCE - 'NEUTRAL'
----------
GOLDMAN RAISES SABMILLER PRICE TARGET TO 3900 (3850) PENCE - 'BUY'
----------
FTSE 250
----------
SHORE CAPITAL CUTS PROVIDENT FINANCIAL TO 'HOLD' ('BUY') - TARGET 2350 PENCE
----------
SOCGEN RAISES HOME RETAIL PRICE TARGET TO 162 (156) PENCE - 'SELL'
----------
SOCGEN INITIATES TALK TALK TELECOM WITH 'HOLD' - TARGET 320 PENCE
----------
GOLDMAN SACHS RAISES TALK TALK TELECOM TO 'BUY' ('NEUTRAL') - TARGET 520.0 (474.4) PENCE
----------
BARCLAYS CUTS COUNTRYWIDE TO 'EQUAL WEIGHT' ('OVERWEIGHT')
----------
BARCLAYS CUTS COUNTRYWIDE PRICE TARGET TO 488.5 (524.8) PENCE
----------
BARCLAYS CUTS AFREN PRICE TARGET TO 28 (50) PENCE - 'UNDERWEIGHT'
----------
Investec Raises JD Sports Fashion Price Target To 610P, Keeps At Buy
----------
Cantor Fitzgerald Raises JD Sports Fashion Target To 550P, Keeps Buy
----------
GOLDMAN CUTS BOVIS HOMES PRICE TARGET TO 1177 (1214) PENCE - 'BUY'
----------
GOLDMAN CUTS BRITVIC PRICE TARGET TO 820 (830) PENCE - 'BUY'
----------
GOLDMAN RAISES ICAP PRICE TARGET TO 455 (395) PENCE - 'NEUTRAL'
----------
GOLDMAN RAISES JUST EAT PRICE TARGET TO 425 (400) PENCE - 'BUY'
----------
GOLDMAN CUTS PZ CUSSONS PRICE TARGET TO 375 (415) PENCE - 'BUY'
----------
MAIN MARKET AND AIM
----------
Numis Cuts MyCelx To Add From Buy, Price Target To 207P From 400P
----------
NUMIS CUTS MINERA IRL PRICE TARGET TO 10 (15) PENCE - 'BUY'
----------
NUMIS CUTS POLAR CAPITAL PRICE TARGET TO 420 (430) PENCE - 'HOLD'
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more
31 Jan 2024 08:55

LONDON MARKET OPEN: Stocks lack direction ahead of Fed, BoE

(Alliance News) - Stock prices in London lacked direction at the open on Wednesday, as investors nervously look ahead to interest rate decisions from the US Federal Reserve and Bank of England.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.